Dr. Reddy’s Recalls Prescription Drug Blister Packages Due to Risk of Poisoning

Due to the extraordinary circumstances surrounding COVID-19, some of the remedies identified in recall press releases may not be available at this time. Consumers should check with recalling firms for further details.

It is important to remember that CPSC and recalling firms urge consumers not to use recalled products.

Recalled Dr. Reddy’s Imatinib Mesylate Tablets 100 mg

Recalled Dr. Reddy’s Imatinib Mesylate Tablets 100 mg

Recalled Dr. Reddy’s Imatinib Mesylate Tablets 400 mg

Recalled Dr. Reddy’s Imatinib Mesylate Tablets 400 mg

Recalled Dr. Reddy’s Pregabalin Capsules 50 mg

Recalled Dr. Reddy’s Pregabalin Capsules 50 mg

Recalled Dr. Reddy’s Pregabalin Capsules 75 mg

Recalled Dr. Reddy’s Pregabalin Capsules 75 mg

Recalled Dr. Reddy’s Pregabalin Capsules 100 mg

Recalled Dr. Reddy’s Pregabalin Capsules 100 mg

Recalled Dr. Reddy’s Pregabalin Capsules 150 mg

Recalled Dr. Reddy’s Sevelamer Carbonate Tablets 800 mg

Recalled Dr. Reddy’s Sevelamer Carbonate Tablets 800 mg

Recalled Dr. Reddy’s Tadalafil Tablets 5 mg

Recalled Dr. Reddy’s Tadalafil Tablets 5 mg

Recalled Dr. Reddy’s Tadalafil Tablets 20 mg

Recalled Dr. Reddy’s Tadalafil Tablets 20 mg

Name of product:

Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tablets 20 mg

Hazard:

The products are prescription medications that were labeled and distributed by Dr. Reddy’s for institutional use only.  The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers.  The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.

Recall date:

February 25, 2021

Recall Details

Description:

This recall involves blister packages of prescription medications.  The name and strength of the medication, “For Institutional Use only,” “Rx Only,” lot number and expiration date are printed on the outside of the package as well as on the individual blister units.  The Dr. Reddy’s logo and NDC number are printed on the outside of the package.  The recalled medications include the following:

Recalled Prescription Drugs

NDC Numbers

Carton Configurations

Lot Numbers

Expiration Dates

Imatinib Mesylate Tablets 100 mg

43598-344-31

3 blister cards of 10 tablets

H2000138

2022-0630

Imatinib Mesylate Tablets 400 mg

43598-345-31

3 blister cards of 10 tablets

H2000127

2022-0630

Pregabalin

Capsules 50 mg

43598-292-66

5 blister cards of 10 capsules

T900876

2021-0630

Pregabalin Capsules 75 mg

43598-293-66

5 blister cards of 10 capsules

T901021

2021-0731

Pregabalin

Capsules 100 mg

43598-294-66

5 blister cards of 10 capsules

T901022

2021-0731

Pregabalin

Capsules 150 mg

43598-295-66

5 blister cards of 10 capsules

T901023

2021-0731

Sevelamer Carbonate

Tablets 800 mg

55111-789-11

4 blister cards of 25 tablets

T801003, T000009, T900221

2020-1031, 2021-1231, 2021-0228

Tadalafil

Tablets 5 mg

43598-575-31

3 blister cards of 10 tablets

T000376

2022-0131

Tadalafil

Tablets 20 mg

43598-573-31

3 blister cards of 10 tablets

T000425

2022-0228

Remedy:

Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy’s for a full refund.

Incidents/Injuries:

No incidents or injuries have been reported.

Sold At:

Beginning in 2018, Dr. Reddy’s sold the recalled medications to wholesalers.  Ultimately, these medications could have been sold to consumers at retail pharmacies in the United States at prices varying based on quantities prescribed, health insurance terms, and other factors.

Manufacturer(s):

Dr. Reddy’s Laboratories, Ltd., of India

Importer(s):

Dr. Reddy’s Laboratories, Inc., of Princeton, N.J.